Lung fluid study for interstitial lung disease diagnosis
Part of Lungs & breathing clinical trials.
This study uses a lung wash (bronchoalveolar lavage) to look at the types of immune cells in the lungs of people with certain lung scarring diseases called interstitial lung diseases (ILD). It may help doctors better understand different ILD types and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have symptoms and imaging findings that suggest a lung scarring disease (ILD).
- You are willing to have a bronchoscopy (a thin tube placed through the mouth or nose to wash the lungs).
- You do not have a serious bleeding problem, recent heart attack, or severe low oxygen levels.
- You do not have other chronic lung diseases like COPD, asthma, or lung cancer.
- You do not have an active lung infection or have taken antibiotics in the last 2 weeks.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special high-resolution CT scan to look at heart and lung problems in people with a type of lung disease that gets worse over time. It may help doctors understand how the heart is affected and guide better care.
This study watches to see if a lung procedure called bronchoscopy is safe for people with interstitial lung disease (a condition where lung tissue becomes scarred or inflamed). Researchers will track how patients do during and after the procedure.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This trial checks how safe a lung biopsy (a small sample taken with a needle) is for people with interstitial lung disease, a condition that causes scarring in the lungs. The goal is to see if the biopsy can be done with fewer risks when guided by ultrasound.
Hear when a new Interstitial Lung Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.